Related Experiment Video
Updated: Jan 9, 2026

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
Orchestrating tumor-immune epigenetics via SERT-H3Q5ser axis
1National Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430199, China; Cancer Biology Research Center (Key Laboratory of the Ministry of Education), National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430199, China; Department of Obstetrics and Gynecology, Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.
The serotonin transporter (SERT) and histone H3 serotonylation (H3Q5ser) link neurotransmitter signals to cancer epigenetics. Targeting this neuro-epigenetic axis may offer new cancer immunotherapies and treatments.
Area of Science:
- Neuroscience
- Cancer Biology
- Epigenetics
Background:
- The serotonin transporter (SERT) regulates extracellular serotonin levels.
- Histone H3 serotonylation (H3Q5ser) is a post-translational modification of histone H3.
- These factors are implicated in integrating extracellular signals with cellular processes.
Purpose of the Study:
- To discuss the role of the SERT-H3Q5ser axis in cancer.
- To explore its impact on tumor immunity and epigenetic plasticity.
- To highlight potential therapeutic strategies targeting this interface.
Main Methods:
- Literature review and synthesis of existing research.
- Analysis of the interplay between SERT, H3Q5ser, and cancer hallmarks.
- Identification of emerging therapeutic targets.
Main Results:
- The SERT-H3Q5ser axis modulates chromatin regulation in cancer.
- This axis influences tumor immune evasion and epigenetic reprogramming.
- It represents a critical neuro-epigenetic interface.
Conclusions:
- The SERT-H3Q5ser axis is a key player in cancer progression and immunity.
- Targeting this neuro-epigenetic interface presents promising therapeutic avenues.
- Further research into this axis could lead to novel cancer treatments.
Related Concept Videos
Tumor Immunotherapy
The Tumor Microenvironment
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation

